Edwin Oldehinkel
YOU?
Author Swipe
View article: Dir-based dose accumulation for parotid glands in head and neck cancer: Accuracy and implications for adaptive radiotherapy
Dir-based dose accumulation for parotid glands in head and neck cancer: Accuracy and implications for adaptive radiotherapy Open
Significant discrepancies were observed in accumulated Dmean of parotid glands between DIR and manual segmentation in candidates for adaptive radiotherapy. Utilizing mid-treatment CT scans offers a practical solution to correct …
View article: Toxicity and Quality of Life After Locoregional Radiotherapy in Patients With Thyroid Cancer
Toxicity and Quality of Life After Locoregional Radiotherapy in Patients With Thyroid Cancer Open
Background Locoregional external beam radiotherapy (EBRT) is selectively used in thyroid cancer patients to induce locoregional control. However, despite technological advances, EBRT remains associated with toxicities. We evaluated thyroid…
View article: Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study
Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study Open
Significant correlations were found for both biomarkers with radiation dose and clinical toxicity endpoints after treatment. Therefore, these markers might be of additional value in NTCP models for cardiac events and might help us unravell…
View article: Optimal timing of re-planning for head and neck adaptive radiotherapy
Optimal timing of re-planning for head and neck adaptive radiotherapy Open
The optimal timing of re-planning was suggested for different organs at risk in head and neck adaptive radiotherapy. Generic scenarios of timing and frequency for re-planning can be applied to guarantee the increase of accumulated mean dos…
View article: External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts
External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts Open
View article: Assessment of residual geometrical errors of clinical target volumes and their impact on dose accumulation for head and neck radiotherapy
Assessment of residual geometrical errors of clinical target volumes and their impact on dose accumulation for head and neck radiotherapy Open
Setup uncertainty setting of 2 mm is possible. The feasibility of using propagated CTVs for error determination is demonstrated.
View article: Challenges and opportunities for proton therapy during pregnancy
Challenges and opportunities for proton therapy during pregnancy Open
During pregnancy, the use of radiation therapy for cancer treatment is often considered impossible due to the assumed associated fetal risks. However, suboptimal treatment of pregnant cancer patients and unjustifiable delay in radiation th…
View article: An efficient strategy to select head and neck cancer patients for adaptive radiotherapy
An efficient strategy to select head and neck cancer patients for adaptive radiotherapy Open
View article: Proton therapy of a pregnant patient with nasopharyngeal carcinoma
Proton therapy of a pregnant patient with nasopharyngeal carcinoma Open
View article: Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients
Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients Open
Sarcopenia in HNC patients was an independent prognostic factor for radiation-induced physician-rated acute grade ≥ 3 dysphagia, which might be explained by its impact on swallowing muscles. However, addition of sarcopenia did not improve …
View article: Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma
Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma Open
Robustly optimised IMPT plans, in combination with volumetric verification imaging and adaptive planning, provided robust target coverage and acceptable OAR dose variation in our NPC cohort when accumulated over longitudinal data.
View article: A novel semi auto-segmentation method for accurate dose and NTCP evaluation in adaptive head and neck radiotherapy
A novel semi auto-segmentation method for accurate dose and NTCP evaluation in adaptive head and neck radiotherapy Open
Human segmentation of the parotid glands remains necessary for accurate interpretation of mean dose and NTCP during ART. Proposed semi auto-segmentation allows NTCP-predictions within 1.5% accuracy for 90% of the cases.
View article: Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation
Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation Open
We established patient-reported toxicity and quality-of-life profiles that showed different patterns for 3 subgroups of patients with HNC. These profiles provide detailed information on the severity and persistence of various symptoms as e…
View article: Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy
Development of advanced preselection tools to reduce redundant plan comparisons in model-based selection of head and neck cancer patients for proton therapy Open
View article: Spleen Dose Influences Overall Survival In The Neo-Adjuvant Treatment Of Esophageal Cancer
Spleen Dose Influences Overall Survival In The Neo-Adjuvant Treatment Of Esophageal Cancer Open
View article: First experience with model-based selection of head and neck cancer patients for proton therapy
First experience with model-based selection of head and neck cancer patients for proton therapy Open
Model-based selection of patients with HNC for proton therapy is clinically feasible. Approximately one third of HNC patients qualify for protons and these patients have the highest probability to benefit from protons in terms of toxicity …
View article: PV-0101: Impact of cardiac dose on survival and toxicity after neo-adjuvant treatment for esophageal cancer
PV-0101: Impact of cardiac dose on survival and toxicity after neo-adjuvant treatment for esophageal cancer Open
View article: PV-0102: Cardiopulmonary toxicity after tri-modality treatment versus surgery alone for esophageal cancer
PV-0102: Cardiopulmonary toxicity after tri-modality treatment versus surgery alone for esophageal cancer Open